We can’t show the full text here under this license.
Abstract
Essence
An encoding spike antigens may strengthen SARS-CoV-2 antibody responses and protection compared with conventional spike mRNA vaccines.
Evidence
Preclinical platform experiments in mice, non-human primates, and hamsters found stronger variant-neutralizing antibodies, at least six-month antibody durability in primates, and complete hamster protection at low mRNA-VLP doses.
Caveat
The evidence is from animal studies, so human safety, immunogenicity, durability, and clinical protection remain untested in this abstract.
Simplified
mRNA Technology